Literature DB >> 22718523

Decades after the cooperative study: a re-examination of systemic blood pressure in sickle cell disease.

Payal C Desai1, Allison M Deal, Julia E Brittain, Susan Jones, Alan Hinderliter, Kenneth I Ataga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22718523      PMCID： PMC3456969          DOI： 10.1002/ajh.23278

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  27 in total

1.  HYPOSTHENURIA IN SICKLE CELL STATES.

Authors:  R T COCHRAN
Journal:  Arch Intern Med       Date:  1963-08

2.  Arterial blood pressure in adult Nigerians with sickle cell anemia.

Authors:  N I Oguanobi; B J C Onwubere; O G Ibegbulam; S O Ike; B C Anisiuba; E C Ejim; O Agwu
Journal:  J Cardiol       Date:  2010-08-19       Impact factor: 3.159

3.  Validation of the DINAMAP ProCare blood pressure device according to the international protocol in an adult population.

Authors:  Annemarie Reinders; Fayrouge Reggiori; Andrew H Shennan
Journal:  Blood Press Monit       Date:  2006-10       Impact factor: 1.444

4.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  Clinical assessment of the DINAMAP ProCare monitor in an adult population according to the British Hypertension Society Protocol.

Authors:  Annemarie de Greeff; Fayrouge Reggiori; Andrew H Shennan
Journal:  Blood Press Monit       Date:  2007-02       Impact factor: 1.444

6.  Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension.

Authors:  Patrícia Gonçalves Teixeira; Antônio Carlos Vieira Cabral; Silvia Passos Andrade; Zilma Silveira Nogueira Reis; Lívia Pieroni Barroso da Cruz; Jacqueline Braga Pereira; Breno Oliveira de Barcelos Martins; Cezar Alencar de Lima Rezende
Journal:  Hypertens Pregnancy       Date:  2008       Impact factor: 2.108

7.  Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.

Authors:  Julia E Brittain; Ben Hulkower; Susan K Jones; Dell Strayhorn; Laura De Castro; Marilyn J Telen; Eugene P Orringer; Alan Hinderliter; Kenneth I Ataga
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

8.  Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study.

Authors:  Joanne Thompson; Marvin Reid; Ian Hambleton; Graham R Serjeant
Journal:  Arch Intern Med       Date:  2007-04-09

9.  Association of coagulation activation with clinical complications in sickle cell disease.

Authors:  Kenneth I Ataga; Julia E Brittain; Payal Desai; Ryan May; Susan Jones; John Delaney; Dell Strayhorn; Alan Hinderliter; Nigel S Key
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

10.  Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy mice.

Authors:  Jonathan Morton; Barbara Coles; Kate Wright; Awen Gallimore; Jason D Morrow; Erin S Terry; Peter B Anning; B Paul Morgan; Vincent Dioszeghy; Hartmut Kühn; Pavlos Chaitidis; Adrian J Hobbs; Simon A Jones; Valerie B O'Donnell
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113
View more
  9 in total

Review 1.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

2.  Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.

Authors:  Abel Makubi; Bruno P Mmbando; Enrico M Novelli; Johnson Lwakatare; Deogratius Soka; Harvest Marik; Kemi Tibarazwa; Mariam Ngaeje; Charles R Newton; Mark T Gladwin; Julie Makani
Journal:  Br J Haematol       Date:  2016-09-21       Impact factor: 6.998

3.  Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Authors:  Paul Drawz; Sabarish Ayyappan; Mehdi Nouraie; Santosh Saraf; Victor Gordeuk; Thomas Hostetter; Mark T Gladwin; Jane Little
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-15       Impact factor: 8.237

4.  New approaches to genetic predisposition for hemorrhagic stroke in sickle cell disease.

Authors:  Robert J Adams; Rufus O Akinyemi; Mayowa O Owolabi; Dan L Lackland; Bruce Ovbiagele
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-27       Impact factor: 3.738

5.  Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease.

Authors:  Enrico M Novelli; Mariana Hildesheim; Caterina Rosano; Rebecca Vanderpool; Marc Simon; Gregory J Kato; Mark T Gladwin
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

6.  Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana.

Authors:  Amma Benneh-Akwasi Kuma; Amma Twumwa Owusu-Ansah; Mary Akua Ampomah; Fredericka Sey; Edeghonghon Olayemi; Mehdi Nouraie; Solomon Fiifi Ofori-Acquah
Journal:  PLoS One       Date:  2018-01-04       Impact factor: 3.240

7.  Clinical characteristics and risk factors of relative systemic hypertension and hypertension among sickle cell patients in Cameroon.

Authors:  Arthemon Nguweneza; Valentina Josiane Ngo Bitoungui; Khuthala Mnika; Gaston Mazandu; Victoria Nembaware; Andre P Kengne; Ambroise Wonkam
Journal:  Front Med (Lausanne)       Date:  2022-07-19

8.  Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition.

Authors:  Pamela L Brito; Alisson F Dos Santos; Hanan Chweih; Maria E Favero; Erica M F Gotardo; Juliete A F Silva; Flavia C Leonardo; Carla F Franco-Penteado; Mariana G de Oliveira; Wilson A Ferreira; Bruna C Zaidan; Athanase Billis; Giorgio Baldanzi; Denise A Mashima; Edson Antunes; Sara T Olalla Saad; Fernando F Costa; Nicola Conran
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

9.  Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.

Authors:  Titilola S Akingbola; Bamidele O Tayo; Babatunde Salako; Jennifer E Layden; Lewis L Hsu; Richard S Cooper; Victor R Gordeuk; Santosh L Saraf
Journal:  Hemoglobin       Date:  2014-06-18       Impact factor: 0.849
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.